https://news.medxy.ai/zh/secondary-autoimmune-and-inflammatory-diseases-post-allogeneic-hematopoietic-stem-cell-transplantation-risk-factors/Medxy AIzh2026-08-02T20:05:18-07:00异基因造血干细胞移植后继发性自身免疫与炎症性疾病：来自EBMT登记研究的发生率、危险因素及临床结局 https://news.medxy.ai/ja/secondary-autoimmune-and-inflammatory-diseases-post-allogeneic-hematopoietic-stem-cell-transplantation-incidence-risk-factors/Medxy AIja2026-08-02T20:05:00-07:00同種造血幹細胞移植後の続発性自己免疫・炎症性疾患：EBMTレジストリからみた発症率・リスク因子・臨床転帰 https://news.medxy.ai/vi/secondary-autoimmune-and-inflammatory-diseases-post-allogeneic-hematopoietic-stem-cell-transplantation-incidence-risk-factors-and-clinical-outcomes/Medxy AIvi2026-08-02T20:04:43-07:00Bệnh tự miễn và viêm thứ phát sau ghép tế bào gốc tạo máu dị thân: Tỷ lệ mắc, yếu tố nguy cơ và kết cục lâm sàng từ sổ đăng ký EBMT https://news.medxy.ai/secondary-autoimmune-and-inflammatory-diseases-post-allogeneic-hematopoietic-stem-cell-transplantation-incidence-risk-factors-and-clinical-outcomes-from-the-ebmt-registry/Medxy AIen2026-08-02T20:03:43-07:00Secondary Autoimmune and Inflammatory Diseases Post-Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Risk Factors, and Clinical Outcomes from the EBMT Registry https://news.medxy.ai/zh/cytogenetic-into-multiple-myeloma-despite-mrd-negativity-post-autologous-stem-cell-transplant/Medxy AIzh2026-08-02T20:02:24-07:00自体干细胞移植后即便 MRD 阴性，多发性骨髓瘤结局仍受细胞遗传学影响 https://news.medxy.ai/ja/cytogenetic-into-multiple-myeloma-outcomes-despite-mrd-negativity-post-autologous-stem-cell-transplant/Medxy AIja2026-08-02T20:02:05-07:00MRD陰性でも残る多発性骨髄腫のリスク：自家移植後の細胞遺伝学的所見が示す予後差 https://news.medxy.ai/cytogenetic-insights-into-multiple-myeloma-outcomes-despite-mrd-negativity-post-autologous-stem-cell-transplant/Medxy AIen2026-08-02T20:00:34-07:00Cytogenetic Insights into Multiple Myeloma Outcomes Despite MRD Negativity Post-Autologous Stem Cell Transplant https://news.medxy.ai/zh/cd19-car-t-cell-therapy-without-lymphodepletion-in-pemphigus-vulgaris/Medxy AIzh2026-08-02T19:57:29-07:00无需淋巴清除的 CD19 CAR T 细胞治疗在寻常型天疱疮中展现希望：RESET-PV 试验带来新启示 https://news.medxy.ai/vi/cd19-car-t-cell-therapy-without-lymphodepletion-shows-promise-in-pemphigus-vulgaris/Medxy AIvi2026-08-02T19:56:54-07:00Liệu pháp tế bào CAR T nhắm CD19 không cần giảm lympho bào cho thấy triển vọng ở pemphigus vulgaris: góc nhìn từ thử nghiệm RESET-PV https://news.medxy.ai/cd19-car-t-cell-therapy-without-lymphodepletion-shows-promise-in-pemphigus-vulgaris-insights-from-the-reset-pv-trial/Medxy AIen2026-08-02T19:55:54-07:00CD19 CAR T-cell Therapy Without Lymphodepletion Shows Promise in Pemphigus Vulgaris: Insights from the RESET-PV Trial https://news.medxy.ai/zh/prognostic-of-moderate-exacerbation-in-copd-patients-insights-from-12-year-mortality/Medxy AIzh2026-08-02T18:47:35-07:00COPD患者单次中度急性加重的预后意义：基于12年死亡结局与未来急性加重风险的分析 https://news.medxy.ai/ja/prognostic-of-single-moderate-exacerbation-in-copd-patients-insights-from-12-year-mortality/Medxy AIja2026-08-02T18:47:14-07:00COPDにおける「1回の中等度増悪」が示す予後への影響――12年死亡データと将来増悪リスク解析から見えること https://news.medxy.ai/vi/prognostic-impact-of-single-moderate-exacerbation-in-copd-patients-insights-from-12-year-mortality/Medxy AIvi2026-08-02T18:46:51-07:00Ý nghĩa tiên lượng của một đợt kịch phát mức độ trung bình đơn lẻ ở bệnh nhân COPD: Góc nhìn từ phân tích tử vong 12 năm và nguy cơ kịch phát trong tương lai https://news.medxy.ai/prognostic-impact-of-single-moderate-exacerbation-in-copd-patients-insights-from-12-year-mortality-and-future-exacerbation-risk-analysis/Medxy AIen2026-08-02T18:45:37-07:00Prognostic Impact of Single Moderate Exacerbation in COPD Patients: Insights from 12-Year Mortality and Future Exacerbation Risk Analysis https://news.medxy.ai/ja/acute-exacerbation-in-fibrotic-interstitial-lung-disease/Medxy AIja2026-08-02T15:50:30-07:00線維性間質性肺疾患の急性増悪：2026年国際ワーキンググループ報告の重要提言 https://news.medxy.ai/zh/acute-exacerbation-in-fibrotic-interstitial-lung-disease-key-recommendations/Medxy AIzh2026-08-02T15:49:36-07:00纤维化性间质性肺疾病急性加重：2026年国际工作组报告的核心建议 https://news.medxy.ai/acute-exacerbation-in-fibrotic-interstitial-lung-disease-key-recommendations-from-the-2026-international-working-group-report/Medxy AIen2026-08-02T15:47:12-07:00Acute Exacerbation in Fibrotic Interstitial Lung Disease: Key Recommendations from the 2026 International Working Group Report https://news.medxy.ai/zh/critical-barriers-to-corneal-cross-linking-in-keratoconus-care-navigating-the-transition-from-photrexa-to-epioxa/Medxy AIzh2026-08-02T15:09:45-07:00美国圆锥角膜治疗中角膜胶原交联的关键障碍：从 Photrexa® 过渡到 Epioxa™ 的挑战 https://news.medxy.ai/vi/critical-barriers-to-corneal-cross-linking-in-us-keratoconus-care-navigating-the-transition-from-photrexa-to-epioxa/Medxy AIvi2026-08-02T15:09:13-07:00Giải quyết các rào cản then chốt đối với liên kết chéo giác mạc trong chăm sóc giác mạc chóp tại Hoa Kỳ: vượt qua quá trình chuyển đổi từ Photrexa® sang Epioxa™ https://news.medxy.ai/addressing-critical-barriers-to-corneal-cross-linking-in-us-keratoconus-care-navigating-the-transition-from-photrexa-to-epioxa/Medxy AIen2026-08-02T15:08:36-07:00Addressing Critical Barriers to Corneal Cross-Linking in US Keratoconus Care: Navigating the Transition from Photrexa® to Epioxa™ https://news.medxy.ai/zh/risk-of-pseudophakic-cystoid-macular-edema-after-cataract-surgery-in-eyes-with-prior-pars-plana-vitrectomy/Medxy AIzh2026-08-02T11:59:24-07:00既往睫状体平坦部玻璃体切除术患者白内障手术后人工晶状体眼囊样黄斑水肿风险升高：大型回顾性队列研究提示 https://news.medxy.ai/ja/risk-of-pseudophakic-cystoid-macular-edema-after-cataract-surgery-in-eyes-with-prior-pars-plana-vitrectomy-insights-from-a-large-retrospective-cohort-study/Medxy AIja2026-08-02T11:59:08-07:00白内障手術後の偽水晶体黄斑浮腫リスクは、既往 pars plana vitrectomy 眼で上昇する：大規模後ろ向きコホート研究からの知見 https://news.medxy.ai/increased-risk-of-pseudophakic-cystoid-macular-edema-after-cataract-surgery-in-eyes-with-prior-pars-plana-vitrectomy-insights-from-a-large-retrospective-cohort-study/Medxy AIen2026-08-02T11:58:07-07:00Increased Risk of Pseudophakic Cystoid Macular Edema After Cataract Surgery in Eyes with Prior Pars Plana Vitrectomy: Insights from a Large Retrospective Cohort Study https://news.medxy.ai/zh/one-year-success-in-endothelial-keratoplasty/Medxy AIzh2026-08-02T11:56:58-07:00DMEK术后1年成功的决定因素：来自糖尿病内皮角膜移植研究的启示 https://news.medxy.ai/ja/one-year-success-in-descemet-membrane-endothelial-keratoplasty/Medxy AIja2026-08-02T11:56:42-07:00Descemet膜内皮角膜移植術の1年成功を左右する因子：Diabetes Endothelial Keratoplasty Studyからの知見 https://news.medxy.ai/vi/one-year-success-in-descemet-membrane-endothelial-keratoplasty-insights-from-the-diabetes-endothelial-keratoplasty-study/Medxy AIvi2026-08-02T11:56:24-07:00Những yếu tố quyết định thành công sau 1 năm của ghép nội mô màng Descemet: Góc nhìn từ Diabetes Endothelial Keratoplasty Study https://news.medxy.ai/determinants-of-one-year-success-in-descemet-membrane-endothelial-keratoplasty-insights-from-the-diabetes-endothelial-keratoplasty-study/Medxy AIen2026-08-02T11:55:41-07:00Determinants of One-Year Success in Descemet Membrane Endothelial Keratoplasty: Insights from the Diabetes Endothelial Keratoplasty Study https://news.medxy.ai/zh/patient-perceptions-of-telehealth-in-head-and-neck-cancer-surveillance/Medxy AIzh2026-08-02T11:51:39-07:00头颈癌随访中的远程医疗：患者如何看待它？一项定性综合 https://news.medxy.ai/vi/patient-perceptions-of-telehealth-use-in-head-and-neck-cancer-surveillance/Medxy AIvi2026-08-02T11:50:54-07:00Người bệnh nhìn nhận telehealth ra sao trong theo dõi ung thư đầu và cổ? Tổng hợp định tính https://news.medxy.ai/patient-perceptions-of-telehealth-use-in-head-and-neck-cancer-surveillance-a-qualitative-synthesis/Medxy AIen2026-08-02T11:49:48-07:00Patient Perceptions of Telehealth Use in Head and Neck Cancer Surveillance: A Qualitative Synthesis https://news.medxy.ai/zh/disparities-in-otolaryngologist-availability-versus-patient-demand-in-the-u-s/Medxy AIzh2026-08-02T11:41:16-07:00供需错位：美国耳鼻咽喉科医生可及性与患者需求的地理差异 https://news.medxy.ai/vi/geographic-disparities-in-otolaryngologist-availability-versus-patient-demand-in-the-u-s/Medxy AIvi2026-08-02T11:40:27-07:00Bản đồ khoảng cách: Chênh lệch địa lý giữa nguồn cung bác sĩ Tai mũi họng và nhu cầu người bệnh tại Hoa Kỳ https://news.medxy.ai/mapping-the-gap-geographic-disparities-in-otolaryngologist-availability-versus-patient-demand-in-the-u-s/Medxy AIen2026-08-02T11:39:50-07:00Mapping the Gap: Geographic Disparities in Otolaryngologist Availability Versus Patient Demand in the U.S. https://news.medxy.ai/zh/colectomy-for-cancer-risk-factors-associations-and-outcomes/Medxy AIzh2026-08-02T11:39:23-07:00结直肠癌择期结肠切除术后急性结肠缺血：风险因素、手术关联与结局 https://news.medxy.ai/ja/colectomy-for-cancer-risk-factors-procedural-associations-and-outcomes/Medxy AIja2026-08-02T11:39:06-07:00がんに対する待機的結腸切除術後の急性大腸虚血：危険因子、術式関連性、転帰 https://news.medxy.ai/vi/elective-colectomy-for-cancer-risk-factors-procedural-associations-and-outcomes/Medxy AIvi2026-08-02T11:38:42-07:00Thiếu máu cục bộ đại tràng cấp tính sau cắt đại tràng chủ động vì ung thư: Yếu tố nguy cơ, mối liên quan với thủ thuật và kết cục https://news.medxy.ai/acute-colonic-ischemia-following-elective-colectomy-for-cancer-risk-factors-procedural-associations-and-outcomes/Medxy AIen2026-08-02T11:37:42-07:00Acute Colonic Ischemia Following Elective Colectomy for Cancer: Risk Factors, Procedural Associations, and Outcomes https://news.medxy.ai/zh/locally-advanced-pancreatic-cancer-hypofractionated-ablative-radiation-therapy/Medxy AIzh2026-08-02T11:35:54-07:00大分割消融放疗为局部晚期胰腺癌争取切除机会与生存获益 https://news.medxy.ai/ja/locally-advanced-pancreatic-cancer-with-hypofractionated-ablative-radiation-therapy/Medxy AIja2026-08-02T11:35:38-07:00低分割高線量放射線療法で切除不能局所進行膵癌の治療成績を高める https://news.medxy.ai/vi/outcomes-in-locally-advanced-pancreatic-cancer-with-hypofractionated-ablative-radiation-therapy/Medxy AIvi2026-08-02T11:35:21-07:00Xạ trị gây hủy diệt khối u phân liều cao: hướng đi triển vọng cho ung thư tụy tiến triển tại chỗ https://news.medxy.ai/maximizing-outcomes-in-locally-advanced-pancreatic-cancer-with-hypofractionated-ablative-radiation-therapy/Medxy AIen2026-08-02T11:34:39-07:00Maximizing Outcomes in Locally Advanced Pancreatic Cancer with Hypofractionated Ablative Radiation Therapy https://news.medxy.ai/zh/burn-injury-immune-activation-neuroinflammation/Medxy AIzh2026-08-02T11:33:36-07:00烧伤如何重塑细胞外囊泡通讯：连接免疫激活与神经炎症 https://news.medxy.ai/ja/burn-injury-immune-activation-and-neuroinflammation/Medxy AIja2026-08-02T11:33:21-07:00熱傷が細胞外小胞の通信機構を再編する：免疫活性化と神経炎症を結び付ける https://news.medxy.ai/vi/burn-injury-linking-immune-activation-and-neuroinflammation/Medxy AIvi2026-08-02T11:33:03-07:00Bỏng nặng làm tái lập trình giao tiếp của túi ngoại bào: Cầu nối giữa hoạt hóa miễn dịch và viêm thần kinh https://news.medxy.ai/burn-injury-reprograms-extracellular-vesicle-communication-linking-immune-activation-and-neuroinflammation/Medxy AIen2026-08-02T11:32:23-07:00Burn Injury Reprograms Extracellular Vesicle Communication: Linking Immune Activation and Neuroinflammation https://news.medxy.ai/zh/mlh1-promoter-hypermethylation-not-impact-survival-outcomes-in-dmmr-endometrial-cancer/Medxy AIzh2026-08-01T09:53:38-07:00MLH1 启动子高甲基化不影响 dMMR 子宫内膜癌接受免疫检查点抑制剂治疗的生存结局 https://news.medxy.ai/ja/mlh1-promoter-hypermethylation-does-not-impact-survival-outcomes-in-dmmr-endometrial-cancer/Medxy AIja2026-08-01T09:53:21-07:00MLH1プロモーター高メチル化は、dMMR子宮内膜癌における免疫チェックポイント阻害療法後の生存に影響しない https://news.medxy.ai/vi/mlh1-promoter-hypermethylation-does-not-impact-survival-outcomes-in-dmmr-endometrial-cancer-with-immune-checkpoint-inhibitors/Medxy AIvi2026-08-01T09:53:03-07:00Tăng methyl hóa promoter MLH1 không làm thay đổi tiên lượng sống còn ở ung thư nội mạc tử cung dMMR điều trị bằng thuốc ức chế điểm kiểm soát miễn dịch https://news.medxy.ai/mlh1-promoter-hypermethylation-does-not-impact-survival-outcomes-in-dmmr-endometrial-cancer-treated-with-immune-checkpoint-inhibitors/Medxy AIen2026-08-01T09:51:47-07:00MLH1 Promoter Hypermethylation Does Not Impact Survival Outcomes in dMMR Endometrial Cancer Treated with Immune Checkpoint Inhibitors https://news.medxy.ai/zh/medical-mistrust-and-patient-in-obgyn-care/Medxy AIzh2026-08-01T08:18:56-07:00弥合信任鸿沟：解读妇产科诊疗中的医疗不信任与患者体验 https://news.medxy.ai/ja/medical-mistrust-and-patient-in-ob-gyn-care/Medxy AIja2026-08-01T08:18:41-07:00OB/GYN診療における医療不信と患者体験を読み解く：分断をつなぐ視点 https://news.medxy.ai/vi/bridging-the-gap-understanding-medical-mistrust-and-patient-in-ob-gyn-care/Medxy AIvi2026-08-01T08:18:22-07:00Thu hẹp khoảng cách: Hiểu về ngờ vực y khoa và trải nghiệm của người bệnh trong chăm sóc OB/GYN https://news.medxy.ai/bridging-the-gap-understanding-medical-mistrust-and-patient-experiences-in-ob-gyn-care/Medxy AIen2026-08-01T08:16:21-07:00Bridging the Gap: Understanding Medical Mistrust and Patient Experiences in OB/GYN Care